Both in Biotechnology
IRulya Therapeutics vs Surrozen
Over the past year IRLA returned +22.8% and SRZN returned +27.9%; their daily moves had a correlation of 0.46.
IRLA +22.8% SRZN +27.9%Growth of $1, one year, split-adjusted
| Metric | IRLA | SRZN |
|---|---|---|
| Price | $39.78 | $31.67 |
| Market cap | $431.3M | $554.1M |
| Today | +3.78% | −0.66% |
| 1 month | +32.6% | +33.3% |
| 6 months | — | +6.0% |
| Year to date | — | +40.1% |
| 1 year | — | +161.4% |
| Revenue growth (YoY) | — | +408.6% |
| Gross margin | — | 100.0% |
| Net margin | — | 640.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 48.1× |
| Net cash | — | $102.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 172.5% |
| Short % of float | 14.2% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).